Finoriq research workspace
Medtronic plc (MDT) Institutional Holdings & 13F Ownership
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare. Review MDT institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
- Company
- Medtronic plc (MDT)
- Ticker
- MDT
- Market Cap
- $106.9B
- Latest Price
- $83.5
- Industry
- Medical Devices
Medtronic plc (MDT) Top Institutional Holders
Top current 13F holders indexed for Medtronic plc (MDT). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | First Eagle Investment ManagementCIK 0001325447 | $870.4M | 1.5% | Filing2026-05-14 |
| 2 | Dodge & Cox (advisor level)CIK 0000200217 | $666.7M | 0.37% | Filing2026-05-14 |
| 3 | Hotchkis & WileyCIK 0001164833 | $415.1M | 1.3% | Filing2026-05-15 |
| 4 | Barrow HanleyCIK 0000313028 | $352.8M | 1.2% | Filing2026-05-13 |
| 5 | Richard PzenaCIK 0001027796 | $273.6M | 0.89% | Filing2026-04-24 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.